Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Sci Rep 7 , 15424
Cytokine modulation by GLP-1
PloS One (2012) 7:e48530
The STEP trials are testing semaglutide at the higher dose of 2.4 mg/week (as compared to 1.0 mg/week for the original diabetes indication), specifically for promoting weight loss, regardless of the presence of type 2 diabetes
Inject into the abdomen, rotating sites daily
Evaluation of antioxidant therapeutic value of ACE inhibitor as adjunct therapy on type 2 diabetes mellitus patients with cardiovascular disease
US$ 20.01
US$ 28.72
US$ 20.41
US$ 29.54
US$ 21.75
